Table 6. Univariate association with recurrence-free survival.
Variables | N | RFS | |||
---|---|---|---|---|---|
HR (95%CI) | P-value | Log-rank P-value | |||
Sex | Male | 10 | 2.98 (0.50–56.65) | 0.26 | 0.29 |
Female | 6 | Ref. | |||
Age | >65 years | 7 | 1.21 (0.23–5.61) | 0.81 | 0.81 |
<65 years | 9 | Ref. | |||
Stage | IV | 3 | 11.43 (1.09–247.04) | 0.04 | 0.01 |
I–III | 13 | Ref. | |||
Postoperative chemotherapy | Done | 10 | 1.74 (0.38–12.22) | 0.49 | 0.50 |
None | 6 | Ref. | |||
IHC | dMMR | 8 | 0.69 (0.14–3.13) | 0.62 | 0.62 |
pMMR | 8 | Ref. | |||
TMB | <10 mut/Mb | 3 | 2.97 (0.41–15.37) | 0.25 | 0.18 |
≥10 mut/Mb | 13 | Ref. | |||
SMAD4 | Mutation | 5 | 4.15 (0.90–21.41) | 0.07 | 0.04 |
Wild | 11 | Ref. |
IHC: immunohistochemical, TMB: tumor mutational burden, mut/MB: mutations per megabase of DNA, MMR: mismatch repair, dMMR: deficient mismatch repair, pMMR: proficient mismatch repair, HR: hazard ratio, RFS: recurrence-free survival.